Amedisys Stock (NASDAQ: AMED) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 280.507K |
Day Range | - - - |
52 Wk Range | 73.100 - 96.436 |
Market Cap | $2.966B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 8.9% |
Days to Cover | 7.27 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amedisys (NASDAQ: AMED) through any online brokerage.
Other companies in Amedisys’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Privia Health Gr (NASDAQ:PRVA).
The latest price target for Amedisys (NASDAQ: AMED) was reported by Raymond James on Tuesday, March 26, 2024. The analyst firm set a price target for 0.00 expecting AMED to fall to within 12 months (a possible -100.00% downside). 18 analyst firms have reported ratings in the last year.
The stock price for Amedisys (NASDAQ: AMED) is $90.78 last updated April 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Amedisys.
Amedisys’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Amedisys.
Amedisys is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.